Involvement of E-cadherin, β-catenin, Cdc42 and CXCR4 in the progression and prognosis of cutaneous melanoma

British Journal of Dermatology

Volumn 157, Issue 6, 2007, Pages 1212-1216

  Tucci, M G ^a   Lucarini, G ^b   Brancorsini, D ^c   Zizzi, A ^b   Pugnaloni, A ^b   Giacchetti, A ^a   Ricotti, G ^a   Biagini, G ^b  

^a INRCA   (Italy)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^c OSPEDALI RIUNITI   (Italy)

Author keywords

catenin; Cdc42; Cutaneous melanoma; CXCR4; E cadherin

Indexed keywords

BETA CATENIN; CHEMOKINE RECEPTOR CXCR4 ANTAGONIST; PROTEIN CDC42; UVOMORULIN;

ANALYTICAL PARAMETERS; ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER MORTALITY; CANCER SURGERY; CANCER SURVIVOR; CARCINOGENESIS; CELL ACTIVATION; CELL INTERACTION; CELL MEMBRANE; CELL MIGRATION; CELL MOTILITY; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; DISEASE FREE INTERVAL; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MELANOMA; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; TUMOR CELL;

ADULT; AGED; BETA CATENIN; CADHERINS; CDC42 GTP-BINDING PROTEIN; CELL PROLIFERATION; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; MIDDLE AGED; PROGNOSIS; RECEPTORS, CXCR4; SKIN NEOPLASMS;

EID: 36149001019     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2007.08246.x     Document Type: Article

References (25)

1. Meier F, Satyamoorthy K, Nesbit M et al. Molecular events in melanoma development and progression. Front Biosci 1988 3 : D1005 10.
2. Clark WH. Tumour progression and the nature of cancer. Br J Cancer 1991 64 : 631 44.
3. Sanders DS, Blessing K, Hassan GA et al. Alterations in cadherin and catenin expression during the biological progression of melanocytic tumours. Mol Pathol 1999 52 : 151 7.
4. Silye R, Karayiannakis AJ, Syrigos KN et al. E-cadherin/catenin complex in benign and malignant melanocytic lesions. J Pathol 1998 186 : 350 5.
5. Tang A, Eller MS, Hara M et al. E-cadherin is the major mediator of human melanocyte adhesion to keratinocytes in vitro. J Cell Sci 1994 107 : 983 92.
6. Hsu MY, Meier FE, Nesbit M et al. E-cadherin expression in melanoma cells restores keratinocyte-mediated growth control and down-regulates expression of invasion-related adhesion receptors. Am J Pathol 2000 156 : 1515 25.
7. Peifer M, Polakis P. Wnt signaling in oncogenesis and embryogenesis: a look outside the nucleus. Science 2000 287 : 1606 9.
8. Oyama T, Kanai Y, Ochiai A et al. A truncated β-catenin disrupts the interaction between E-cadherin and α-catenin: a cause of loss of intercellular adhesiveness in human cancer cell lines. Cancer Res 1994 54 : 6282 7.
9. Kassis J, Lauffenburger DA, Turner T, Wells A. Tumor invasion as dysregulated cell motility. Semin Cancer Biol 2001 11 : 105 17.
10. Jung ID, Lee J, Yun SY et al. Cdc42 and Rac1 are necessary for autotaxin-induced tumor cell motility in A2058 melanoma cells. FEBS Lett 2002 532 : 351 6.
11. Goteri G, Ciavattini A, Lucarini G et al. Expression of motility-related molecule Cdc42 in endometrial tissue of women with adenomyosis and ovarian endometriomata. Fertil Steril 2006 86 : 559 65.
12. Murakami T, Maki W, Cardones AR et al. Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells. Cancer Res 2002 62 : 7328 34.
13. Muller A, Homey B, Soto H et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001 410 : 50 6.
14. Clark WH Jr., From L, Bernardino EA, Mihm MC. The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res 1969 29 : 705 27.
15. Breslow A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 1970 172 : 902 8.
16. Pecina-Slaus N, Zigmund M, Kusec V et al. E-cadherin and β-catenin expression patterns in malignant melanoma assessed by image analysis. J Cutan Pathol 2007 34 : 239 46.
17. Haass NK, Herlyn M. Normal human melanocyte homeostasis as a paradigm for understanding melanoma. J Investig Dermatol Symp Proc 2005 10 : 153 63.
18. Hsu M, Andl T, Li G et al. Cadherin repertoire determines partner-specific gap junctional communication during melanoma progression. J Cell Sci 2000 113 : 1535 42.
19. El-Bahrawy M, El-Masry N, Alison M et al. Expression of β-catenin in basal cell carcinoma. Br J Dermatol 2003 148 : 964 70.
20. cas. Nat Cell Biol 1999 1 : 507 13.
21. Scala S, Ottaviano A, Ascierto PA et al. Expression of CXCR4 predicts poor prognosis in patients with malignant melanoma. Clin Cancer Res 2005 11 : 1835 41.
22. Robledo MM, Bartolomè RA, Longo N et al. Expression of functional chemokine receptors CXCR3 and CXCR4 on human melanoma cells. J Biol Chem 2001 276 : 45098 105.
23. Murakami T, Cardones AR, Hwang ST. Chemokine receptors and melanoma metastasis. J Dermatol Sci 2004 36 : 71 8.
24. Takeuchi H, Fujimoto A, Tanaka M et al. CCL21 chemokine regulates chemokine receptor CCR7 bearing malignant melanoma cells. Clin Cancer Res 2004 10 : 2351 8.
25. Kawada K, Sonoshita M, Sakashita H et al. Pivotal role of CXCR3 in melanoma cell metastasis to lymph nodes. Cancer Res 2004 64 : 4010 17.